TAM receptor signaling and autoimmune disease

Current Opinion in Immunology

Volumn 22, Issue 6, 2010, Pages 740-746

  Rothlin, Carla V ^a   Lemke, Greg ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUCOCORTICOID; GROWTH ARREST SPECIFIC PROTEIN 6; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LIVER X RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLSERINE; PROTEIN AXL; PROTEIN MER; PROTEIN S; PROTEIN TYRO3; PROTEIN TYROSINE KINASE; TAM RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CHRONIC INFLAMMATION; DENDRITIC CELL; DISEASE CONTROL; DISEASE PREDISPOSITION; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; LIGAND BINDING; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RETINA DYSTROPHY; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 78649848107     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.10.001     Document Type: Review

References (66)

1. Gaipl U.S., Kuhn A., Sheriff A., Munoz L.E., Franz S., Voll R.E., Kalden J.R., Herrmann M. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006, 9:173-187.
2. Ronnblom L., Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 2008, 17:394-399.
3. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
4. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007, 25:419-441.
5. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., Theofilopoulos A.N. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003, 197:777-788.
6. Lai C., Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991, 6:691-704.
7. O'Bryan J.P., Frye R.A., Cogswell P.C., Neubauer A., Kitch B., Prokop C., Espinosa R., Le Beau M.M., Earp H.S., Liu E.T. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991, 11:5016-5031.
8. Lemke G., Rothlin C.V. Immunobiology of the TAM receptors. Nat Rev Immunol 2008, 8:327-336.
9. Stitt T.N., Conn G., Gore M., Lai C., Bruno J., Radziejewski C., Mattsson K., Fisher J., Gies D.R., Jones P.F., et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995, 80:661-670.
10. Godowski P.J., Mark M.R., Chen J., Sadick M.D., Raab H., Hammonds R.G. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995, 82:355-358.
11. Mark M.R., Chen J., Hammonds R.G., Sadick M., Godowsk P.J. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem 1996, 271:9785-9789.
12. Varnum B.C., Young C., Elliott G., Garcia A., Bartley T.D., Fridell Y.W., Hunt R.W., Trail G., Clogston C., Toso R.J., et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995, 373:623-626.
13. Nagata K., Ohashi K., Nakano T., Arita H., Zong C., Hanafusa H., Mizuno K. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 1996, 271:30022-30027.
14. Huang M., Rigby A.C., Morelli X., Grant M.A., Huang G., Furie B., Seaton B., Furie B.C. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 2003, 10:751-756.
15. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2216.
16. Ravichandran K.S., Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007, 7:964-974.
17. Lemke G., Burstyn-Cohen T. TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci 2010, 1209:23-29. doi:10.1111/j.1749-6632.2010.05744.x.
18. Prasad D., Rothlin C.V., Burrola P., Burstyn-Cohen T., Lu Q., Garcia de Frutos P., Lemke G. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci 2006, 33:96-108.
19. Rezende S.M., Simmonds R.E., Lane D.A. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004, 103:1192-1201.
20. Walker F.J. Regulation of vitamin K-dependent protein S, Inactivation by thrombin. J Biol Chem 1984, 259:10335-10339.
21. Esmon C.T. The interactions between inflammation and coagulation. Br J Haematol 2005, 131:417-430.
22. Esmon C.T. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006, 32(Suppl. 1):49-60.
23. Niessen F., Schaffner F., Furlan-Freguia C., Pawlinski R., Bhattacharjee G., Chun J., Derian C.K., Andrade-Gordon P., Rosen H., Ruf W. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008, 452:654-658.
24. Lu Q., Gore M., Zhang Q., Camenisch T., Boast S., Casagranda F., Lai C., Skinner M.K., Klein R., Matsushima G.K., et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 1999, 398:723-728.
25. Camenisch T.D., Koller B.H., Earp H.S., Matsushima G.K. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol 1999, 162:3498-3503.
26. Burstyn-Cohen T., Heeb M.J., Lemke G. Lack of Protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest 2009, 119:2942-2953.
27. Angelillo-Scherrer A., de Frutos P., Aparicio C., Melis E., Savi P., Lupu F., Arnout J., Dewerchin M., Hoylaerts M., Herbert J., et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001, 7:215-221.
28. Saller F., Brisset A.C., Tchaikovski S.N., Azevedo M., Chrast R., Fernandez J.A., Schapira M., Hackeng T.M., Griffin J.H., Angelillo-Scherrer A. Generation and phenotypic analysis of protein S-deficient mice. Blood 2009, 114:2307-2314.
29. Yanagita M., Ishimoto Y., Arai H., Nagai K., Ito T., Nakano T., Salant D.J., Fukatsu A., Doi T., Kita T. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest 2002, 110:239-246.
30. Xiong W., Chen Y., Wang H., Wu H., Lu Q., Han D. Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phagocytic function of Sertoli cells. Reproduction 2008, 135:77-87.
31. Chen Y., Wang H., Qi N., Wu H., Xiong W., Ma J., Lu Q., Han D. Functions of TAM RTKs in regulating spermatogenesis and male fertility in mice. Reproduction 2009, 138:655-666.
32. Duncan J.L., LaVail M.M., Yasumura D., Matthes M.T., Yang H., Trautmann N., Chappelow A.V., Feng W., Earp H.S., Matsushima G.K., et al. An RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol Vis Sci 2003, 44:826-838.
33. Gal A., Li Y., Thompson D.A., Weir J., Orth U., Jacobson S.G., Apfelstedt-Sylla E., Vollrath D. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000, 26:270-271.
34. Shahzadi A., Riazuddin S.A., Ali S., Li D., Khan S.N., Husnain T., Akram J., Sieving P.A., Hejtmancik J.F., Riazuddin S. Nonsense mutation in MERTK causes autosomal recessive retinitis pigmentosa in a consanguineous Pakistani family. Br J Ophthalmol 2010.
35. Mackay D.S., Henderson R.H., Sergouniotis P.I., Li Z., Moradi P., Holder G.E., Waseem N., Bhattacharya S.S., Aldahmesh M.A., Alkuraya F.S., et al. Novel mutations in MERTK associated with childhood onset rod-cone dystrophy. Mol Vis 2010, 16:369-377.
36. Charbel Issa P., Bolz H.J., Ebermann I., Domeier E., Holz F.G., Scholl H.P. Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene. Br J Ophthalmol 2009, 93:920-925.
37. Brea-Fernandez A.J., Pomares E., Brion M.J., Marfany G., Blanco M.J., Sanchez-Salorio M., Gonzalez-Duarte R., Carracedo A. Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa. Br J Ophthalmol 2008, 92:1419-1423.
38. D'Cruz P.M., Yasumura D., Weir J., Matthes M.T., Abderrahim H., LaVail M.M., Vollrath D. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 2000, 9:645-651.
39. Nandrot E., Dufour E.M., Provost A.C., Pequignot M.O., Bonnel S., Gogat K., Marchant D., Rouillac C., Sepulchre de Conde B., Bihoreau M.T., et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis 2000, 7(6 Pt B):586-599.
40. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211.
41. Seitz H.M., Camenisch T.D., Lemke G., Earp H.S., Matsushima G.K. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol 2007, 178:5635-5642.
42. Rothlin C.V., Ghosh S., Zuniga E.I., Oldstone M.B., Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007, 131:1124-1136.
43. Tibrewal N., Wu Y., D'Mello V., Akakura R., George T.C., Varnum B., Birge R.B. Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappaB transcriptional activation. J Biol Chem 2008, 283:3618-3627.
44. Scutera S., Fraone T., Musso T., Cappello P., Rossi S., Pierobon D., Orinska Z., Paus R., Bulfone-Paus S., Giovarelli M. Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway. J Immunol 2009, 183:3004-3013.
45. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., Trinchieri G. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005, 201:1157-1167.
46. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005, 201:1435-1446.
47. Sharif M.N., Sosic D., Rothlin C.V., Kelly E., Lemke G., Olson E.N., Ivashkiv L.B. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006, 203:1891-1901.
48. Wormald S., Hilton D.J. The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathways. Curr Opin Hematol 2007, 14:9-15.
49. Yoshimura A., Nishinakamura H., Matsumura Y., Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005, 7:100-110.
50. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'Neill L.A., Hertzog P.J. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 2006, 7:148-155.
51. Sen P., Wallet M.A., Yi Z., Huang Y., Henderson M., Mathews C.E., Earp H.S., Matsushima G., Baldwin A.S., Tisch R.M. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 2007, 109:653-660.
52. Wallet M.A., Sen P., Flores R.R., Wang Y., Yi Z., Huang Y., Mathews C.E., Earp H.S., Matsushima G., Wang B., et al. MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med 2008, 205:219-232.
53. Cohen P.L., Caricchio R., Abraham V., Camenisch T.D., Jennette J.C., Roubey R.A., Earp H.S., Matsushima G., Reap E.A. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002, 196:135-140.
54. Lu Q., Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001, 293:306-311.
55. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009, 9:845-857.
56. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004, 304:1147-1150.
57. Finnemann S.C., Nandrot E.F. MerTK activation during RPE phagocytosis in vivo requires alphaVbeta5 integrin. Adv Exp Med Biol 2006, 572:499-503.
58. Shao W.H., Zhen Y., Eisenberg R.A., Cohen P.L. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol 2009, 133:138-144.
59. Meesters E.W., Hansen H., Spronk H.M., Hamulyak K., Rosing J., Rowshani A.T., ten Berge I.J., ten Cate H. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis 2007, 18:21-28.
60. Brouwer J.L., Bijl M., Veeger N.J., Kluin-Nelemans H.C., van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004, 104:143-148.
61. Song K.S., Park Y.S., Kim H.K. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2000, 43:557-560.
62. Suh C.H., Hilliard B., Li S., Merrill J.T., Cohen P.L. TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R146.
63. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
64. McColl A., Bournazos S., Franz S., Perretti M., Morgan B.P., Haslett C., Dransfield I. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 2009, 183:2167-2175.
65. Gonzalez N.A., Bensinger S.J., Hong C., Beceiro S., Bradley M.N., Zelcer N., Deniz J., Ramirez C., Diaz M., Gallardo G., et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009, 31:245-258.
66. Rahman ZS, Shao WH, Khan TN, Zhen Y, Cohen PL: Impaired Apoptotic cell clearance in the germinal center by mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J Immunol 2010, [Epub ahead of print].